IP Library Assignment 067203/0281
Patent Assignment
Reel/Frame 067203/0281

Assignment of Assignor's Interest

Recorded: 2024-04-23 Pages: 30
Assignor
PALADIN LABS INC.
Executed: 2024-04-23
Assignee
PALADIN PHARMA INC.
100 ALEXIS-NIHON BLVD, #600, SAINT-LAURENT, H4M 2P2, CANADA
Covered Properties (19)
Amphiphilic Diblock, Triblock and Star-Block Copolymers and Their Pharmaceutical Compositions
Patent: 7,018,655 →
Application: 10/101,093 →
Publication: US 2003/0181613
Ph-Sensitive Block Copolymers for Pharmaceutical Compositions
Patent: 7,094,810 →
Application: 10/607,446 →
Publication: US 2004/0072784
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Patent: 7,262,253 →
Application: 10/727,083 →
Publication: US 2005/0119404
Controlled-release compositions
Patent: 8,487,002 →
Application: 11/111,996 →
Publication: US 2006/0240107
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Patent: 7,988,998 →
Application: 11/112,008 →
Publication: US 2007/0003618
Process for the Preparation of Amphiphilic Poly(N-Vinyl-2-Pyrrolidone) Block Copolymers
Patent: 7,838,600 →
Application: 12/211,551 →
Publication: US 2009/0012240
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Patent: 8,895,066 →
Application: 12/252,117 →
Publication: US 2009/0130183
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,448 →
Application: 12/336,495 →
Publication: US 2009/0175937
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,449 →
Application: 12/639,664 →
Publication: US 2010/0239662
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Patent: 9,090,649 →
Application: 12/996,362 →
Publication: US 2011/0077286
Narcotic Drug Formulations with Decreased Abuse Potential
Patent: 8,460,640 →
Application: 13/133,141 →
Publication: US 2011/0237615
Misuse Preventative, Controlled Release Formulation
Patent: 8,691,270 →
Application: 13/919,476 →
Publication: US 2013/0344142
Misuse Preventative, Controlled Release Formulation
Patent: 8,685,447 →
Application: 13/919,499 →
Publication: US 2014/0004191
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,833 →
Application: 14/195,813 →
Publication: US 2014/0193494
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,013 →
Application: 14/195,833 →
Publication: US 2014/0248346
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,834 →
Application: 14/305,895 →
Publication: US 2014/0294954
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,014 →
Application: 14/305,935 →
Publication: US 2014/0294955
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Patent: 9,719,091 →
Application: 14/810,148 →
Publication: US 2016/0145613
Solid Formulations of Liquid Biologically Active Agents
Application: 15/817,907 →
Publication: US 2018/0140706
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory Grant of Security Interest in United States Patents May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
Assignment of Assignor's Interest Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
Change of Name Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
Change of Name Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
Release of Security Interest Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0376 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067221/0958 →
Assignment of Assignor's Interest Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0714 →
Assignment of Assignor's Interest Jun 20, 2024
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067778/0988 →
Assignment of Assignor's Interest Jun 20, 2024
From: PALADIN LABS EUROPE LIMITED
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067779/0054 →
Change of Name Jun 20, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 067994/0211 →
Security Interest Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 068031/0059 →
Security Interest Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068031/0202 →
Security Interest Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 67245 Frame: 714. Assignor(S) Hereby Confirms the Assignment. Apr 17, 2025
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 070887/0702 →
Release of Security Interest Jul 23, 2025
From: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
To: ENDO OPERATIONS LIMITED
Reel/Frame 071804/0377 →
Release of Security Interest Jul 23, 2025
From: GOLDMAN SACHS BANK USA
To: ENDO OPERATIONS LIMITED
Reel/Frame 071804/0384 →